S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1
Abstract Background The anti-tumor effects of S-allylcysteine (SAC), a water-soluble garlic derivative, on human ovarian cancer cells have been previous studied in vitro and in vivo models but the precise epigenetic molecular mechanisms are still unclear. This study aimed to investigate the epigenet...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13048-018-0412-1 |
_version_ | 1797973056176521216 |
---|---|
author | Yasi Xu Dan Su Lucheng Zhu Shirong Zhang Shenglin Ma Kan Wu Qiang Yuan Nengming Lin |
author_facet | Yasi Xu Dan Su Lucheng Zhu Shirong Zhang Shenglin Ma Kan Wu Qiang Yuan Nengming Lin |
author_sort | Yasi Xu |
collection | DOAJ |
description | Abstract Background The anti-tumor effects of S-allylcysteine (SAC), a water-soluble garlic derivative, on human ovarian cancer cells have been previous studied in vitro and in vivo models but the precise epigenetic molecular mechanisms are still unclear. This study aimed to investigate the epigenetic mechanism of SAC. Methods Human epithelial ovarian cancer cell line A2780 was selected. Cell proliferation and cell cycle was analyzed. DNA methylation, DNA methyltransferase (DNMT) activity, tumor suppressor gene expressions, as well as protein expression were analyzed. Results SAC could inhibit the proliferation of A2780 cells in dose- and time-dependent manners (the IC50 was 16.25 mmol/L and 5.25 mmol/L at 48 h and 72 h). Treatment of A2780 cells with SAC resulted in G1/S phase arrest. SAC treatment decreased global DNA methylation levels in A2780 cells in a dose-dependent manner. SAC decreased the levels of 5-methylcytosine, DNMT activity, messenger RNA (mRNA) and protein levels of DNMT1. Additionally, SAC treatment resulted in re-expression of the mRNA and proteins of silenced tumor suppressor gene CDKN1A accompany with reduced cell division control 2 expression. Conclusion Our data indicated the potential therapeutic effects of SAC on the human ovarian carcinoma cell line A2780 in vitro. The epigenetic mechanism of action of SAC may have important implications for epigenetic therapy. |
first_indexed | 2024-04-11T03:58:11Z |
format | Article |
id | doaj.art-23b80899f04e470987d72ea6fdae0a4b |
institution | Directory Open Access Journal |
issn | 1757-2215 |
language | English |
last_indexed | 2024-04-11T03:58:11Z |
publishDate | 2018-05-01 |
publisher | BMC |
record_format | Article |
series | Journal of Ovarian Research |
spelling | doaj.art-23b80899f04e470987d72ea6fdae0a4b2023-01-02T00:02:09ZengBMCJournal of Ovarian Research1757-22152018-05-011111810.1186/s13048-018-0412-1S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1Yasi Xu0Dan Su1Lucheng Zhu2Shirong Zhang3Shenglin Ma4Kan Wu5Qiang Yuan6Nengming Lin7Hangzhou Translational Medicine Research Center, Zhejiang Chinese Medical University, Hangzhou First People’s HospitalDepartment of Pathology, Zhejiang Cancer HospitalDepartment of Oncology, Hangzhou Cancer HospitalHangzhou Translational Medicine Research Center, Zhejiang Chinese Medical University, Hangzhou First People’s HospitalHangzhou Translational Medicine Research Center, Zhejiang Chinese Medical University, Hangzhou First People’s HospitalDepartment of Oncology, Hangzhou Cancer HospitalCollege of Pharmaceutical Science, Zhejiang Chinese Medical UniversityHangzhou Translational Medicine Research Center, Zhejiang Chinese Medical University, Hangzhou First People’s HospitalAbstract Background The anti-tumor effects of S-allylcysteine (SAC), a water-soluble garlic derivative, on human ovarian cancer cells have been previous studied in vitro and in vivo models but the precise epigenetic molecular mechanisms are still unclear. This study aimed to investigate the epigenetic mechanism of SAC. Methods Human epithelial ovarian cancer cell line A2780 was selected. Cell proliferation and cell cycle was analyzed. DNA methylation, DNA methyltransferase (DNMT) activity, tumor suppressor gene expressions, as well as protein expression were analyzed. Results SAC could inhibit the proliferation of A2780 cells in dose- and time-dependent manners (the IC50 was 16.25 mmol/L and 5.25 mmol/L at 48 h and 72 h). Treatment of A2780 cells with SAC resulted in G1/S phase arrest. SAC treatment decreased global DNA methylation levels in A2780 cells in a dose-dependent manner. SAC decreased the levels of 5-methylcytosine, DNMT activity, messenger RNA (mRNA) and protein levels of DNMT1. Additionally, SAC treatment resulted in re-expression of the mRNA and proteins of silenced tumor suppressor gene CDKN1A accompany with reduced cell division control 2 expression. Conclusion Our data indicated the potential therapeutic effects of SAC on the human ovarian carcinoma cell line A2780 in vitro. The epigenetic mechanism of action of SAC may have important implications for epigenetic therapy.http://link.springer.com/article/10.1186/s13048-018-0412-1EpigeneticDNA methylationS-allylcysteineOvarian cancer |
spellingShingle | Yasi Xu Dan Su Lucheng Zhu Shirong Zhang Shenglin Ma Kan Wu Qiang Yuan Nengming Lin S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1 Journal of Ovarian Research Epigenetic DNA methylation S-allylcysteine Ovarian cancer |
title | S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1 |
title_full | S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1 |
title_fullStr | S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1 |
title_full_unstemmed | S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1 |
title_short | S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1 |
title_sort | s allylcysteine suppresses ovarian cancer cell proliferation by dna methylation through dnmt1 |
topic | Epigenetic DNA methylation S-allylcysteine Ovarian cancer |
url | http://link.springer.com/article/10.1186/s13048-018-0412-1 |
work_keys_str_mv | AT yasixu sallylcysteinesuppressesovariancancercellproliferationbydnamethylationthroughdnmt1 AT dansu sallylcysteinesuppressesovariancancercellproliferationbydnamethylationthroughdnmt1 AT luchengzhu sallylcysteinesuppressesovariancancercellproliferationbydnamethylationthroughdnmt1 AT shirongzhang sallylcysteinesuppressesovariancancercellproliferationbydnamethylationthroughdnmt1 AT shenglinma sallylcysteinesuppressesovariancancercellproliferationbydnamethylationthroughdnmt1 AT kanwu sallylcysteinesuppressesovariancancercellproliferationbydnamethylationthroughdnmt1 AT qiangyuan sallylcysteinesuppressesovariancancercellproliferationbydnamethylationthroughdnmt1 AT nengminglin sallylcysteinesuppressesovariancancercellproliferationbydnamethylationthroughdnmt1 |